Publications
Selected Publications
2009
Fu Y, Chang A, Chang L, Niessen K, Eapen S,
Setiadi A, & Karsan A. Differential regulation of TGFbeta signaling
pathways by notch in human endothelial cells. J Biol Chem, 2009.
View Abstract
Vercauteren SM,
Bashashati A, Wu D, Brinkman RR, Eaves C, Eaves A, & Karsan A. Reduction in multi-lineage and erythroid progenitors
distinguishes myelodysplastic syndromes from non-malignant cytopenias. Leuk Res, 2009.
View Abstract
2008
Starczynowski DT, Vercauteren S, Telenius A, Sung S, Tohyama K,
Brooks-Wilson A, Spinelli JJ,
Eaves CJ, Eaves AC, Horsman DE, Lam WL, Karsan A.
High-resolution whole genome
tiling path array CGH analysis of CD34+ cells from patients with
low-risk myelodysplastic syndromes reveals cryptic copy number
alterations and predicts overall and leukemia-free survival. Blood.
2008
Oct 15;112(8):3412-24.
View Abstract
Niessen K, Fu Y, Chang L,
Hoodless PA, McFadden D, Karsan A. Slug
is a direct Notch target required for initiation of cardiac cushion
cellularization. J Cell Biol. 2008 Jul 28;182(2):315-25.
View Abstract
Karsan A. Notch and integrin affinity: a sticky situation. Sci Signal 1
(2): pe2, 2008.
View
Abstract
Niessen K, & Karsan A. Notch signaling in cardiac development. Circ Res
102 (10): 1169-81, 2008.
Toll-free link to full text
Wu C, Cipollone J, Maines-Bandiera S, Tan C, Karsan A, Auersperg N, &
Roskelley CD. The morphogenic function of E-cadherin-mediated adherens
junctions in epithelial ovarian carcinoma formation and progression.
Differentiation 76 (2): 193-205, 2008.
View Abstract
2007
Larrivee
B, & Karsan A. Involvement of marrow-derived endothelial cells in vascularization. Handb Exp Pharmacol
(180): 89-114, 2007.
View Abstract
Leong
KG, Niessen K, Kulic I, Raouf A, Eaves C, Pollet I, & Karsan A.
Jagged1-mediated Notch activation induces epithelial-to-mesenchymal
transition through Slug-induced repression of E-cadherin. J Exp Med 204
(12): 2935-48, 2007.
View Abstract
Niessen K, & Karsan A. Notch signaling in the developing cardiovascular
system. Am J Physiol Cell Physiol 293 (1): C1-11, 2007.
Toll-free link to full text
Zhande R, Dauphinee SM, Thomas JA, Yamamoto M, Akira S, & Karsan A. FADD
negatively regulates lipopolysaccharide signaling by impairing
interleukin-1 receptor-associated kinase 1-MyD88 interaction. Mol Cell
Biol 27 (21): 7394-404, 2007.
View Abstract
Zhande R, & Karsan A. Erythropoietin promotes survival of primary human
endothelial cells through PI3K-dependent, NF-kappaB-independent
upregulation of Bcl-xL. Am J Physiol Heart Circ Physiol 292 (5):
H2467-74, 2007.
View Abstract
2006
Dauphinee SM, & Karsan A. Lipopolysaccharide signaling in endothelial
cells. Lab Invest 86 (1): 9-22, 2006.
View Abstract
Larrivee B,
Olive PL,
& Karsan A. Tissue distribution of endothelial cells in vivo following
intravenous injection. Exp Hematol 34 (12): 1741-5, 2006.
View Abstract
Leong KG, & Karsan A. Recent insights into the role of Notch signaling
in tumorigenesis. Blood 107 (6): 2223-33, 2006.
View Abstract
Murphy S, Larrivee B, Pollet I, Craig KS, Williams DE, Huang XH, Abbott
M, Wong F, Curtis C, Conrads TP, Veenstra T, Puri M, Hsiang Y, Roberge
M, Andersen RJ, & Karsan A. Identification of sokotrasterol sulfate as a
novel proangiogenic steroid. Circ Res 99 (3): 257-65, 2006.
View Abstract
Noseda M, Fu Y, Niessen K, Wong F, Chang L, McLean G, & Karsan A. Smooth
Muscle alpha-actin is a direct target of Notch/CSL.
Circ Res 98 (12): 1468-70, 2006.
View Abstract
Noseda M, & Karsan A. Notch and minichromosome maintenance (MCM)
proteins: integration of two ancestral pathways in cell cycle control.
Cell Cycle 5 (23): 2704-9, 2006.
View Abstract
2005
Harfouche R, Malak NA, Brandes RP, Karsan A, Irani K, & Hussain SN.
Roles of reactive oxygen species in angiopoietin-1/tie-2 receptor
signaling. Faseb J 19 (12): 1728-30, 2005.
View Abstract
Hood BL, Lucas DA, Kim G, Chan KC, Blonder J, Issaq HJ, Veenstra TD,
Conrads TP, Pollet I, & Karsan A. Quantitative analysis of the low
molecular weight serum proteome using 18O stable isotope labeling in a
lung tumor xenograft mouse model. J Am Soc Mass Spectrom 16 (8):
1221-30, 2005.
View Abstract
Karsan A. The role of notch in modeling and maintaining the vasculature.
Can J Physiol Pharmacol 83 (1): 14-23, 2005.
View Abstract
Karsan A, Blonder J, Law J, Yaquian E, Lucas DA, Conrads TP, & Veenstra
T. Proteomic analysis of lipid microdomains from lipopolysaccharide-activated
human endothelial cells. J Proteome Res 4 (2): 349-57, 2005.
View Abstract
Karsan A, Eigl BJ, Flibotte S, Gelmon K, Switzer P, Hassell P, Harrison
D, Law J, Hayes M, Stillwell M, Xiao Z, Conrads TP, & Veenstra T.
Analytical and preanalytical biases in serum proteomic pattern analysis
for breast cancer diagnosis. Clin Chem 51 (8): 1525-8, 2005.
View Abstract
Karsan A, Pollet I, Yu LR, Chan KC, Conrads TP, Lucas DA, Andersen
R, & Veenstra T. Quantitative proteomic analysis of sokotrasterol
sulfate-stimulated primary human endothelial cells. Mol Cell
Proteomics 4 (2): 191-204, 2005.
View Abstract
Larrivee B, & Karsan A. Isolation and culture of primary endothelial
cells. Methods Mol Biol 290: 315-29, 2005.
View Abstract
Larrivee B, Niessen K, Pollet I, Corbel SY, Long M, Rossi FM, Olive
PL, & Karsan A. Minimal contribution of marrow-derived endothelial
precursors to tumor vasculature. J Immunol 175 (5): 2890-9, 2005.
View Abstract
Larrivee B, Pollet I, & Karsan A. Activation of vascular endothelial
growth factor receptor-2 in bone marrow leads to accumulation of
myeloid cells: role of granulocyte-macrophage colony-stimulating
factor. J Immunol 175 (5): 3015-24, 2005.
View Abstract
Noseda M, Niessen K, McLean G, Chang L, & Karsan A. Notch-dependent
cell cycle arrest is associated with downregulation of
minichromosome maintenance proteins. Circ Res 97 (2): 102-4, 2005.
View Abstract
2004
MacKenzie F, Duriez P, Larrivee B, Chang L, Pollet I, Wong F, Yip C, &
Karsan A. Notch4-induced inhibition of endothelial sprouting requires
the ankyrin repeats and involves signaling through RBP-Jkappa. Blood 104
(6): 1760-8, 2004.
View Abstract
MacKenzie F, Duriez P, Wong F, Noseda M, & Karsan A. Notch4 inhibits
endothelial apoptosis via RBP-Jkappa-dependent and -independent
pathways. J Biol Chem 279 (12): 11657-63, 2004.
View Abstract
Noseda M, Chang L, McLean G, Grim JE, Clurman BE, Smith LL, & Karsan
A. Notch activation induces endothelial cell cycle arrest and
participates in contact inhibition: role of p21Cip1 repression. Mol
Cell Biol 24 (20): 8813-22, 2004.
View Abstract
Noseda M, McLean G, Niessen K, Chang L, Pollet I, Montpetit R,
Shahidi R, Dorovini-Zis K, Li L, Beckstead B, Durand RE, Hoodless
PA, & Karsan A. Notch activation results in phenotypic and
functional changes consistent with endothelial-to-mesenchymal
transformation. Circ Res 94 (7): 910-7, 2004.
View Abstract
Wong F, Hull C, Zhande R, Law J, & Karsan A. Lipopolysaccharide
initiates a TRAF6-mediated endothelial survival signal. Blood 103
(12): 4520-6, 2004.
View Abstract
2003
Harfouche R, Gratton JP, Yancopoulos GD, Noseda M, Karsan A, & Hussain
SN. Angiopoietin-1 activates both anti- and proapoptotic mitogen-activated
protein kinases. Faseb J 17 (11): 1523-5, 2003.
View Abstract
Larrivee B, Lane DR, Pollet I, Olive PL, Humphries RK, & Karsan A.
Vascular endothelial growth factor receptor-2 induces survival of
hematopoietic progenitor cells. J Biol Chem 278 (24): 22006-13, 2003.
View Abstract
Pollet I, Opina CJ, Zimmerman C, Leong KG, Wong F, & Karsan A. Bacterial
lipopolysaccharide directly induces angiogenesis through TRAF6-mediated
activation of NF-kappaB and c-Jun N-terminal kinase. Blood 102 (5):
1740-2, 2003.
View Abstract
2002
Hull
C, McLean G, Wong F, Duriez PJ, & Karsan A. Lipopolysaccharide signals
an endothelial apoptosis pathway through TNF receptor-associated factor
6-mediated activation of c-Jun NH2-terminal kinase. J Immunol 169 (5):
2611-8, 2002.
View Abstract
Leong KG, Hu X, Li L, Noseda M, Larrivee B, Hull C, Hood L, Wong F, &
Karsan A. Activated Notch4 inhibits angiogenesis: role of beta
1-integrin activation. Mol Cell Biol 22 (8): 2830-41, 2002.
View Abstract
Levkau B, Kenagy RD, Karsan A, Weitkamp B, Clowes AW, Ross R, & Raines
EW. Activation of metalloproteinases and their association with
integrins: an auxiliary apoptotic pathway in human endothelial cells.
Cell Death Differ 9 (12): 1360-7, 2002.
View Abstract
Litwin C, Leong KG, Zapf R, Sutherland H, Naiman SC, & Karsan A. Role of
the microenvironment in promoting angiogenesis in acute myeloid
leukemia. Am J Hematol 70 (1): 22-30, 2002.
View Abstract
Zheng X, Karsan A, Duronio V,
Chu
F, Walker DC, Bai TR, & Schellenberg RR. Interleukin-3, but not
granulocyte-macrophage colony-stimulating factor and interleukin-5,
inhibits apoptosis of human basophils through phosphatidylinositol
3-kinase: requirement of NF-kappaB-dependent and -independent pathways.
Immunology 107 (3): 306-15, 2002.
View Abstract
2001
Churg A, Dai J, Zay K, Karsan A, Hendricks R, Yee C, Martin R, MacKenzie
R, Xie C, Zhang L, Shapiro S, & Wright JL. Alpha-1-antitrypsin and a
broad spectrum metalloprotease inhibitor, RS113456, have similar acute
anti-inflammatory effects. Lab Invest 81 (8): 1119-31, 2001.
View Abstract
Imanishi T, Hano T, Nishio I, Han DK, Schwartz SM, & Karsan A. Apoptosis
of vascular smooth muscle cells is induced by Fas ligand derived from
endothelial cells. Jpn Circ J 65 (6): 556-60, 2001.
View Abstract
Roskelley CD, Williams DE, McHardy LM, Leong KG, Troussard A, Karsan A,
Andersen RJ, Dedhar S, & Roberge M. Inhibition of tumor cell invasion
and angiogenesis by motuporamines. Cancer Res 61 (18): 6788-94, 2001.
View Abstract
2000
Duriez PJ, Wong F, Dorovini-Zis K, Shahidi R, & Karsan A. A1 functions
at the mitochondria to delay endothelial apoptosis in response to tumor
necrosis factor. J Biol Chem 275 (24): 18099-107, 2000.
View Abstract
Larrivee B, & Karsan A. Signaling pathways induced by vascular
endothelial growth factor (review). Int J Mol Med 5 (5): 447-56,
2000.
View Abstract
Leong KG, & Karsan A. Signaling pathways mediated by tumor necrosis
factor alpha. Histol Histopathol 15 (4): 1303-25, 2000.
View Abstract
1999
Schwartz BR, Karsan A, Bombeli T, & Harlan JM. A novel beta 1 integrin-dependent
mechanism of leukocyte adherence to apoptotic cells. J Immunol 162 (8):
4842-8, 1999.
View Abstract
Stempien-Otero A, Karsan A, Cornejo CJ, Xiang H, Eunson T, Morrison RS,
Kay M, Winn R, & Harlan J. Mechanisms of hypoxia-induced endothelial
cell death. Role of p53 in apoptosis. J Biol Chem 274 (12): 8039-45,
1999.
View Abstract
Zen K, Karsan A, Stempien-Otero A, Yee E, Tupper J, Li X, Eunson T, Kay
MA, Wilson CB, Winn RK, & Harlan JM. NF-kappaB activation is required
for human endothelial survival during exposure to tumor necrosis
factor-alpha but not to interleukin-1beta or lipopolysaccharide. J Biol
Chem 274 (40): 28808-15, 1999.
View Abstract
1998
Choi KB, Wong F, Harlan JM, Chaudhary PM, Hood L, & Karsan A.
Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent
pathway. J Biol Chem 273 (32): 20185-8, 1998.
View Abstract
Chuang PI, Yee E, Karsan A, Winn RK, & Harlan JM. A1 is a constitutive
and inducible Bcl-2 homologue in mature human neutrophils. Biochem
Biophys Res Commun 249 (2): 361-5, 1998.
View Abstract
Hu X, Yee E, Harlan JM, Wong F, & Karsan A. Lipopolysaccharide induces
the antiapoptotic molecules, A1 and A20, in microvascular endothelial
cells. Blood 92 (8): 2759-65, 1998.
View Abstract
Karsan A, Cornejo CJ, Winn RK, Schwartz BR, Way W, Lannir N,
Gershoni-Baruch R, Etzioni A, Ochs HD, & Harlan JM. Leukocyte
Adhesion Deficiency Type II is a generalized defect of de novo
GDP-fucose
biosynthesis. Endothelial cell fucosylation is not required for
neutrophil rolling on human nonlymphoid endothelium. J Clin Invest
101 (11): 2438-45, 1998.
View Abstract
Mitra D, Kim J, MacLow C, Karsan A, & Laurence J. Role of caspases 1
and 3 and Bcl-2-related molecules in endothelial cell apoptosis
associated with thrombotic microangiopathies. Am J Hematol 59 (4):
279-87, 1998.
View Abstract
Zen K, Karsan A, Eunson T, Yee E, & Harlan JM. Lipopolysaccharide-induced
NF-kappaB activation in human endothelial cells involves degradation
of IkappaBalpha but not IkappaBbeta. Exp Cell Res 243 (2): 425-33,
1998.
View Abstract
1997
Bombeli T, Karsan A, Tait JF, & Harlan JM. Apoptotic vascular
endothelial cells become procoagulant. Blood 89 (7): 2429-42, 1997.
View Abstract
Karsan A, Yee E, Poirier GG, Zhou P, Craig R, & Harlan JM.
Fibroblast growth factor-2 inhibits endothelial cell apoptosis by
Bcl-2-dependent and independent mechanisms. Am J Pathol 151 (6):
1775-84, 1997.
View Abstract
Pang XP, Hershman JM, & Karsan A. TNF-alpha induction of A1
expression in human cancer cells. Oncol Res 9 (11-12): 623-7, 1997.
View Abstract
Slowik MR, Min W, Ardito T, Karsan A, Kashgarian M, & Pober JS.
Evidence that tumor necrosis factor triggers apoptosis in human
endothelial cells by interleukin-1-converting enzyme-like
protease-dependent and -independent pathways. Lab Invest 77 (3):
257-67, 1997.
View Abstract
1996
Karsan A, & Harlan JM. Modulation of endothelial cell apoptosis:
mechanisms and pathophysiological roles. J Atheroscler Thromb 3 (2):
75-80, 1996.
View Abstract
Karsan A, Yee E, & Harlan JM. Endothelial cell death induced by
tumor necrosis factor-alpha is inhibited by the Bcl-2 family member,
A1. J Biol Chem 271 (44): 27201-4, 1996.
View Abstract
Karsan A, Yee E, Kaushansky K, & Harlan JM. Cloning of human Bcl-2
homologue: inflammatory cytokines induce human A1 in cultured
endothelial cells. Blood 87 (8): 3089-96, 1996.
View Abstract